State Street Corp Sells 56,301 Shares of Liquidia Co. (NASDAQ:LQDA)

State Street Corp trimmed its position in shares of Liquidia Co. (NASDAQ:LQDA) by 2.5% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 2,175,378 shares of the company’s stock after selling 56,301 shares during the quarter. State Street Corp’s holdings in Liquidia were worth $21,754,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of LQDA. Bank of New York Mellon Corp raised its holdings in shares of Liquidia by 18.2% during the second quarter. Bank of New York Mellon Corp now owns 207,961 shares of the company’s stock valued at $2,496,000 after acquiring an additional 32,076 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Liquidia by 398.1% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,039 shares of the company’s stock worth $156,000 after purchasing an additional 10,421 shares in the last quarter. Deuterium Capital Management LLC purchased a new stake in shares of Liquidia in the 2nd quarter worth about $120,000. Rhumbline Advisers boosted its stake in shares of Liquidia by 12.4% during the 2nd quarter. Rhumbline Advisers now owns 80,164 shares of the company’s stock valued at $962,000 after purchasing an additional 8,871 shares in the last quarter. Finally, Arizona State Retirement System boosted its stake in shares of Liquidia by 10.7% during the 2nd quarter. Arizona State Retirement System now owns 13,842 shares of the company’s stock valued at $166,000 after purchasing an additional 1,341 shares in the last quarter. 64.54% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Roger Jeffs sold 8,053 shares of the stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $11.11, for a total transaction of $89,468.83. Following the transaction, the chief executive officer now owns 812,193 shares in the company, valued at $9,023,464.23. This represents a 0.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Rajeev Saggar sold 2,260 shares of Liquidia stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $11.11, for a total transaction of $25,108.60. Following the completion of the sale, the insider now directly owns 207,383 shares of the company’s stock, valued at approximately $2,304,025.13. This trade represents a 1.08 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,007 shares of company stock worth $245,780 in the last three months. Insiders own 30.10% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on LQDA. Scotiabank initiated coverage on shares of Liquidia in a report on Wednesday, October 16th. They issued a “sector outperform” rating and a $30.00 price objective for the company. Lifesci Capital began coverage on Liquidia in a research note on Thursday, October 3rd. They issued an “outperform” rating and a $30.00 target price for the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $19.00 price target on shares of Liquidia in a research note on Thursday, November 14th. Wells Fargo & Company initiated coverage on Liquidia in a research report on Friday. They set an “overweight” rating and a $20.00 price objective for the company. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $29.00 target price on shares of Liquidia in a research report on Thursday, November 14th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $25.38.

Liquidia Stock Up 3.1 %

Shares of Liquidia stock opened at $11.44 on Tuesday. The company has a 50-day simple moving average of $10.92 and a two-hundred day simple moving average of $11.12. Liquidia Co. has a 52-week low of $8.26 and a 52-week high of $16.99.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).